Indicators

Markets:

News

Latest News about BIIB

Recent news which mentions BIIB

...

12 13 14 15 16 17 18 19 20

...

Price Over Earnings Overview: Biogen

March 31, 2023

Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug

March 31, 2023

Biogen Unusual Options Activity

March 23, 2023

11 Analysts Have This to Say About Biogen

March 23, 2023

7 Blue-Chip Stocks Sitting in the Sweet Spot

March 23, 2023

FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder

March 23, 2023

iMetabolic BioPharma's Alzheimer's Disease Therapeutic Innovation Is A Breakthrough Three-Pronged Approach

March 22, 2023

Veterans Health Administration will cover new Alzheimer’s drug. Why won’t Medicare?

March 22, 2023

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

March 21, 2023

Wall Street predicts approval for another ALS drug

March 21, 2023

Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit

March 21, 2023

Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo

March 20, 2023

Should You Buy Biogen Before a Big July Decision?

March 19, 2023

Price Over Earnings Overview: Biogen

March 17, 2023

(BIIB) - Analyzing Biogen's Short Interest

March 17, 2023

Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year

March 16, 2023

Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments

March 16, 2023

Biogen's Debt Overview

March 15, 2023

Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity

March 14, 2023

1 Reason to Buy Biogen Stock, and 1 Reason to Sell

March 14, 2023

Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone

March 13, 2023

Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock

March 09, 2023

Why Shares of Anavex Life Sciences Rose 12.4% in February

March 06, 2023

Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment

March 06, 2023

Medicare just crushed the hopes of 750,000 Alzheimer’s patients a year

March 03, 2023

What Does Biogen's Debt Look Like?

March 02, 2023

Peering Into Biogen's Recent Short Interest

March 01, 2023

FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments

February 28, 2023

Why Reata Pharmaceuticals Shares Are Falling Monday?

February 27, 2023

Analyst Initiates Coverage of GE Healthcare, Says' Path To Greatness Well-Paved'

February 17, 2023

...

12 13 14 15 16 17 18 19 20

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.